Alibaba Group Holding Ltd. Sponsored ADR is a premium stock of StocksGuide. Please log in to activate an alert for Alibaba Group Holding Ltd. Sponsored ADR.
Register for Free
Please register for free to add Alibaba Group Holding Ltd. Sponsored ADR to your portfolio.
Alibaba Group Holding Ltd. Sponsored ADR Stock News
Quarterly results out late Thursday from Chinese e-commerce giants Alibaba and JD.com underscored the weakness in China's consumer market. Alibaba's Hong Kong-listed shares rose by 5% Friday in afternoon trading, while those of JD were up 9%.
In one of his more shocking moves, Michael Burry of ‘ The Big Short ' has decided to sell all of his gold and direct his investments elsewhere – including consumerism, office space for technology companies, the strength of the United States dollar, Chinese stocks, and the U.S. job market.
Tepper reduced Appaloosa's stakes in Alibaba, Amazon, Microsoft, Meta, and Alphabet in Q2. There's no clear reason why the billionaire hedge fund manager sold these top AI stocks.
Wall Street is having a stellar day following strong retail sales data , with the major indexes completely recovering their early month deficits caused by a global market selloff.
Alibaba's ADR price continues to find resilience at the $80 level, in line with our previous expectations for continued range-bound trading despite gradual, yet consistent, improvements to quarterly fundamentals. Although a tepid revenue showing at first glance, a deeper dive shows sustained margin expansion in the long-run as its revamped business model under new management delivers durable sc...
Alibaba Group reported disappointing financial results for the June quarter of 2024, missing both revenue and profit expectations. The company's struggles reflect broader challenges in its core domestic market, where competition and consumer sentiment have exerted significant pressure.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.